Travere Therapeutics, Inc. · NASDAQ:TVTX
Rote William E. sold 9,100 Travere Therapeutics, Inc. shares (Form 4)
Traded Apr 22, 2026 · Filed Apr 23, 2026
On Apr 22, 2026, Rote William E. (Chief Research Officer) sold 9,100 Travere Therapeutics, Inc. shares at US$39.09 for US$356K under a trading plan, leaving 113,987 shares. Filed Apr 23, 2026 (Form 4).
- Sold
- 9,100 shares
- Price
- US$39.09
- Value
- US$356K
- Holding after
- 113,987 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Research Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 22, 2026 | Common Stock | Sale | 9,100 | US$39.09 | 113,987 | Direct |
Source
Related
- Travere Therapeutics, Inc.
- Rote William E.
- Travere Therapeutics, Inc. shareholders
- Form 4 · Rote William E. · Sep 17, 2026
- Form 4 · Rote William E. · May 6, 2026
- Form 4 · Rote William E. · Apr 15, 2026
- Form 4 · Dube Eric M · Oct 19, 2026
- Form 4 · Heerma Peter · Sep 17, 2026
- Form 4 · Dube Eric M · Sep 17, 2026
- Form 4 · Inrig Jula · Sep 17, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026